The Glaucoma Foundation announces a new granting platform focused on the topic of intraocular pressure-independent mechanisms of optic nerve degeneration in glaucoma. Examples of research that may be considered range from basic science to clinical interventions, such as genetics and genomic medicine, disease modeling, assessment of ocular perfusion, artificial intelligence, and clinical research. A priority will be given to novel proposals with a viable study hypothesis that can lead to impactful results that are fundable at the NIH level. Each one-year grant award is $60,000 and is potentially renewable for a second year.
Grant applications on this topic as well as exfoliation syndrome and exfoliation glaucoma will be accepted in Spring 2021. For more information click here.
DR. AHTI TARKKANEN ACCEPTS THE 2020 DR. ROBERT RITCH AWARD FOR EXCELLENCE AND INNOVATION IN GLAUCOMA
TUNE INTO THIS RECENT MEETING WITH MEMBERS OF TGF'S BOARD
The Glaucoma and Exfoliation Syndrome-Back to Basics
For the past as it ten years, TGF has been funding research in exfoliation syndrome (XFS) and exfoliation glaucoma. In this recorded ZOOM meeting with the members of our board of directors, Dr. Louis Pasquale explains XFS, what we believe contributes to its development, and what further funding might accomplish.
The Patricia Hill - Dr. Sanford Eisenberg Fellowship in Glaucoma
This spring, The Glaucoma Foundation awarded the inaugural Patricia Hill-Dr. Sanford Eisenberg Fellowship in Glaucoma to Dr. Jessica Scott and Dr. Sejal Patel, both fellows at Columbia University Medical Center in New York.
Dr. Sejal Patel has been focusing her goals on meaningful patient access. In medical school, she was part of a team that served the remote community of the Himalayan mountain range where care is available only biannually. During her residency, she returned to India to perform extracapsular cataract extraction on some of the same patients.
Dr. Patel trained for medical school and residency at the Montefiore Medical Campus in the Bronx, NY. Working with the local Guyanese population there, she realized that for many of these patients, glaucoma had progressed more than in other subgroups. This confirms her belief in the need for more and better education and access to care.
Dr. Scott’s interest in glaucoma started when she was a child. Her father, a comprehensive ophthalmologist, taught her and her siblings about the basic structures of the eye during their free time at home.
As she progressed in her career from ophthalmic techncian to resident, her interest in glaucoma deepened. “It is the perfect marriage between being in the clinic and the operating room,” she says. “In addition, the advent of emerging new glaucoma medications, surgeries, and devices, make a career in glaucoma even more exciting.”